Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
Background: Ventilator-associated pneumonia (VAP) due to multidrug-resistant organisms (MDROs) is associated with a significant mortality in the Intensive Care Unit (ICU). The aim of this study was to compare the efficacy and safety of extended infusion of meropenem and nebulized amikacin on VAP cau...
Main Authors: | Mona Ahmed Ammar, Waleed Abdalla |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Saudi Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2018;volume=12;issue=1;spage=89;epage=94;aulast=Ammar |
Similar Items
-
Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
by: Samar S. Mabrouk, et al.
Published: (2023-07-01) -
Comparative Study between Combined Intravenous and Nebulized Amikacin versus Intravenous Amikacin Alone for Treatment of Ventilator Associated Pneumonia
by: Sameh Seyam, et al.
Published: (2022-06-01) -
Metabolomics reveals the mechanism of action of meropenem and amikacin combined in the treatment of Pseudomonas aeruginosa
by: Hai Yang, et al.
Published: (2023-12-01) -
Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
by: Guangna Cao, et al.
Published: (2022-03-01) -
Assessment of the Ototoxic Effects of Amikacin and Meropenem among Neonates in a Tertiary Government Hospital
by: Edgar Jake A. Agullo, et al.
Published: (2014-12-01)